Canaccord Genuity Maintains Buy on Blend Labs, Lowers Price Target to $4.5

Blend Labs, Inc. Class A

Blend Labs, Inc. Class A

BLND

0.00

Canaccord Genuity analyst Joseph Vafi maintains Blend Labs (NYSE: BLND) with a Buy and lowers the price target from $5.25 to $4.5.